Jayaram H, Kolko M, Friedman DS, Gazzard G (2023) Glaucoma: now and beyond. Lancet 402(10414):1788–1801
Díez-Álvarez L, Beltrán-Agullo L, Loscos J, Pazos M, Ponte-Zúñiga B, Pinazo-Durán MD et al (2023) Advanced glaucoma. Clinical practice guideline. Arch Soc Esp. Oftalmol (English Edition) 98(1):18–39
Topouzis F, Coleman AL, Choplin N, Bethlem MM, Hill R, Yu F et al (1999) Follow-up of the original cohort with the Ahmed glaucoma valve implant11The views expressed herein are those of the authors and are not the official opinions of the department of the navy, the department of defense, or the United States government. Am J Ophthalmol 128(2):198–204
Riva I, Roberti G, Katsanos A, Oddone F, Quaranta L (2017) A review of the Ahmed glaucoma valve implant and comparison with other surgical operations. Adv Ther 34(4):834–847
Budenz DL, Barton K, Gedde SJ, Feuer WJ, Schiffman J, Costa VP et al (2015) Five-year treatment outcomes in the Ahmed baerveldt comparison study. Ophthalmology 122(2):308–316
Christakis PG, Kalenak JW, Tsai JC, Zurakowski D, Kammer JA, Harasymowycz PJ et al (2016) The Ahmed versus Baerveldt study. Ophthalmology 123(10):2093–2102
Pakravan M, Esfandiari H, Yazdani S, Doozandeh A, Dastborhan Z, Gerami E et al (2019) Clinical outcomes of Ahmed glaucoma valve implantation in pediatric glaucoma. Eur J Ophthalmol 29(1):44–51
Sheheitli H, Tirpack AR, Parrish RK (2019) Which patients would most likely to benefit: MIGS or MEGS, which one is it? Asia-Pac J Ophthalmol 8(6):436–440
Khawaja AP, Stalmans I, Aptel F, Barton K, Beckers H, Klink T et al (2022) Expert consensus on the use of the PRESERFLO™ MicroShunt device in the treatment of glaucoma: a modified Delphi panel. Ophthalmol Ther 11(5):1743–1766
PubMed PubMed Central Google Scholar
Ma D, Chen CB, Jhanji V, Xu C, Yuan XL, Liang JJ et al (2020) Expression of SARS-CoV-2 receptor ACE2 and TMPRSS2 in human primary conjunctival and pterygium cell lines and in mouse cornea. Eye 34(7):1212–1219
CAS PubMed PubMed Central Google Scholar
Gupta R (2021) A graft-free scleral sleeve technique of Ahmed glaucoma valve implantation in refractory glaucoma- rising to the challenge of COVID-19 pandemic. Indian J Ophthalmol 69(6):1623–1625
PubMed PubMed Central Google Scholar
Morales-Fernandez L, Garcia-Bardera J, Pérez-García P, Saenz-Frances F, Garcia-Saenz S, Martinez-de-la-Casa JM et al (2024) Trends in glaucoma surgery in a tertiary hospital in Spain: 2010–2022. Eur J Ophthalmol 29(35):938
Majoulet A, Scemla B, Hamard P, Brasnu E, Hage A, Baudouin C et al (2022) Safety and efficacy of the Preserflo® microshunt in refractory glaucoma: a one-year study. J Clin Med 11(23):456. https://doi.org/10.7759/cureus.28288
De Gregorio A, Pedrotti E, Stevan G, Bertoncello A, Morselli S (2018) XEN glaucoma treatment system in the management of refractory glaucomas: a short review on trial data and potential role in clinical practice. Clin Ophthalmol 12:773–782
PubMed PubMed Central Google Scholar
Fili S, Kontopoulou K, Vastardis I, Perdikakis G, Kohlhaas M. PreserFloTM MicroShunt Versus Trabeculectomy in Patients With Moderate to Advanced Open-Angle Glaucoma: 12-Month Follow-Up of a Single-Center Prospective Study. Cureus. 2022 Aug 23;
Medert CM, Sun CQ, Vanner E, Parrish RK, Wellik SR (2021) The influence of etiology on surgical outcomes in neovascular glaucoma. BMC Ophthalmol 21(1):1–10
Ramdas WD, Pals J, Rothova A, Wolfs RCW (2019) Efficacy of glaucoma drainage devices in uveitic glaucoma and a meta-analysis of the literature. Graefe’s Arch Clin Exp Ophthalmol 257(1):143–151
Triolo G, Wang J, Aguilar-Munoa S, Jayaram H, Barton K (2023) Preserflo microshunt implant for the treatment of refractory uveitic glaucoma: 36-month outcomes. Eye (Lond) 37(12):2535–2541
Burgos-Blasco B, García-Feijóo J, Gines-Gallego C, Perucho-Gonzalez L, Fernandez-Vigo JI, Martinez de la Casa JM et al (2023) Efficacy and safety of the PreserFlo implant with mitomycin C in childhood glaucoma after previous failed glaucoma surgeries. Graefe’s Arch Clin Exp Ophthalmol 261(5):1349–1357
García-Bardera J, Garcia-Feijoo J, Morales-Fernández L, Heredia-Pastor C, Ponce-de-León-Miguel A, García-Bermúdez M et al (2025) Outcomes of Preserflo MicroShunt implantation in refractory childhood glaucoma following Ahmed glaucoma valve surgery. Ophthalmol Glaucoma S2589–4196(25):00079–00081. https://doi.org/10.1016/j.ogla.2025.04.011
Evers C, Anton A, Böhringer D, Kallee S, Keye P, Neß T et al (2024) XEN®-45 implantation for refractory Uveitic glaucoma. Graefe’s Arch Clin Exp Ophthalmol 262(3):937–948
Serrar Y, Rezkallah A, Kodjikian L, Poli M, Mathis T, Denis P (2023) XEN® 63 gel stent to treat a refractory uveitic glaucoma: a case report. Eur J Ophthalmol 33(4):32–36
Tang Y, Shi Y, Fan Z (2023) The mechanism and therapeutic strategies for neovascular glaucoma secondary to diabetic retinopathy. Front Endocrinol 14:1102361
Rezkallah A, Loria O, Mathis T, Chacun S, Denis P, Kodjikian L (2022) Preserflo microshunt surgery for ocular hypertension following intravitreal fluocinolone acetonide implant removal: a case report. Case Rep Ophthalmol 13(3):1024–1029
PubMed PubMed Central Google Scholar
Rezkallah A, Mathis T, Denis P, Kodjikian L (2019) XEN Gel stent to treat intraocular hypertension after dexamethasone-implant intravitreal injections: 5 cases. J Glaucoma 28(1):e5-9
Cornée C, Orignac I, Wargny M, Clément M, Varnier C, Le Meur G et al (2022) Implantation du dispositif XEN 45® dans la chirurgie du glaucome: étude bicentrique bispective s’intéressant au glaucome cortisonique par rapport au glaucome primitif à angle ouvert. J Fr Ophtalmol 45(8):872–882
Gedde SJ, Schiffman JC, Feuer WJ, Herndon LW, Brandt JD, Budenz DL (2012) Treatment outcomes in the tube versus trabeculectomy (TVT) study after five years of follow-up. Am J Ophthalmol 153(5):803.e2
Sihota R, Angmo D, Ramaswamy D, Dada T (2018) Simplifying, “target” intraocular pressure for different stages of primary open-angle glaucoma and primary angle-closure glaucoma. Indian J Ophthalmol 66(4):495
PubMed PubMed Central Google Scholar
Iwao K, Inatani M, Seto T, Takihara Y, Ogata-Iwao M, Okinami S et al (2014) Long-term outcomes and prognostic factors for trabeculectomy with mitomycin C in eyes with Uveitic glaucoma. J Glaucoma 23(2):88–94
Chow A, Burkemper B, Varma R, Rodger DC, Rao N, Richter GM (2018) Comparison of surgical outcomes of trabeculectomy, Ahmed shunt, and Baerveldt shunt in uveitic glaucoma. J Ophthalmic Inflamm Infect 8(1):9
PubMed PubMed Central Google Scholar
Kwon HJ, Kong YXG, Tao LW, Lim LL, Martin KR, Green C et al (2017) Surgical outcomes of trabeculectomy and glaucoma drainage implant for uveitic glaucoma and relationship with uveitis activity. Clin Exp Ophthalmol 45(5):472–480
Ventura-Abreu N, Mendes-Pereira J, Pazos M, Muniesa-Royo MJ, Gonzalez-Ventosa A, Romero-Nuñez B et al (2021) Surgical approach and outcomes of Uveitic glaucoma in a tertiary hospital. J Curr Glaucoma Pract 15(2):52–57
PubMed PubMed Central Google Scholar
Senthil S, Dada T, Das T, Kaushik S, Puthuran G, Philip R et al (2021) Neovascular glaucoma-a review. Indian J Ophthalmol 69:525–534
PubMed PubMed Central Google Scholar
Heuer DK, Gressel MG, Parrish RK, Anderson DR, Hodapp E, Palmberg PF (1984) Trabeculectomy in aphakic eyes. Ophthalmology 91(9):1045–1051
Landers J, Martin K, Sarkies N, Bourne R, Watson P (2012) A Twenty-year follow-up study of trabeculectomy: risk factors and outcomes. Ophthalmology 119(4):694–702
Lopes EMP, Ludovico IC, Mota CDMG, Xavier ACM, Duarte AF, Cardigos JSD (2024) Surgical management of glaucoma secondary to indirect carotid-cavernous fistula: a case report. Int J Surg Case Rep 116:109317
PubMed PubMed Central Google Scholar
Kwon YH, Taylor JM, Hong S, Honkanen RA, Zimmerman MB, Alward WLM et al (2001) Long-term results of eyes with penetrating keratoplasty and glaucoma drainage tube implant. Ophthalmology 108(2):272–278
Lieberman RA, Maris PJG, Monroe HM, Al-Aswad LA, Bansal R, Lopez R et al (2012) Corneal graft survival and intraocular pressure control in coexisting penetrating Keratoplasty and pars Plana Ahmed glaucoma valves. Cornea 31(4):350–358
Comments (0)